Bleakley Financial Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.28 Trillion
- Q3 2024
A detailed history of Bleakley Financial Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 5,915 shares of REGN stock, worth $4.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
5,915
Previous 13,629
56.6%
Holding current value
$4.1 Million
Previous $14.3 Billion
56.59%
% of portfolio
0.19%
Previous 0.41%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,526Shares Held
82.7MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.46 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.19 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.4 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.98 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...